SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038868
Filing Date
2024-04-01
Accepted
2024-04-01 07:30:36
Documents
82
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tcrt-20231231.htm   iXBRL 10-K 2315802
2 EX-10.59 tcrt-ex10_59.htm EX-10.59 47798
3 EX-10.60 tcrt-ex10_60.htm EX-10.60 85653
4 EX-10.61 tcrt-ex10_61.htm EX-10.61 50600
5 EX-10.62 tcrt-ex10_62.htm EX-10.62 77943
6 EX-23.1 tcrt-ex23_1.htm EX-23.1 3823
7 EX-31.1 tcrt-ex31_1.htm EX-31.1 13371
8 EX-32.1 tcrt-ex32_1.htm EX-32.1 7312
9 EX-97.1 tcrt-ex97_1.htm EX-97.1 37870
10 GRAPHIC img160836378_0.jpg GRAPHIC 15323
11 GRAPHIC img160836378_1.jpg GRAPHIC 42879
12 GRAPHIC img160836378_2.jpg GRAPHIC 361119
  Complete submission text file 0000950170-24-038868.txt   10458053

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcrt-20231231.xsd EX-101.SCH 1523167
85 EXTRACTED XBRL INSTANCE DOCUMENT tcrt-20231231_htm.xml XML 1264571
Mailing Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33038 | Film No.: 24805539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)